GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models

GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models

Cachexia is a complicated metabolic syndrome mainly associated with cancers, characterized by extreme weight loss and muscle wasting. It is a debilitating condition that negatively affects prognosis and survival. However, there is currently no effective pharmacological intervention that can reverse...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu Huang, Jinyong Wang, Xiling Wei, Hui Zhang, Wei Shang, Xiangling Zhang, Lanjiao Zhai, Xi Chen, Huiming Li, Suofu Qin
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:mAbs
Subjects:
Cachexia
Cancer
Chemotherapy
GDF15
Nanobody
Online Access:https://www.tandfonline.com/doi/10.1080/19420862.2024.2416453
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items